XML 63 R56.htm IDEA: XBRL DOCUMENT v3.6.0.2

Subsequent Events - Additional Information (Detail)					1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended		17 Months Ended
	May 11, 2016 USD ($)	Mar. 29, 2016 USD ($)	Mar. 29, 2016 ILS (₪)	Oct. 08, 2015 USD ($)	Aug. 31, 2014 USD ($)	Aug. 31, 2014 ILS (₪)	Sep. 30, 2016 USD ($)	Sep. 30, 2015 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2015 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Sep. 30, 2015
Research and development expense							$ 340,051	$ 15,613	$ 602,575	$ 477,607	$ 822,759	$ 836,698
Convertible Debt [Member]
Loans Receivable	$ 750,000
Convertible Debt [Member] | Maximum [Member]
Loans Receivable				$ 500,000
Israeli Innovation Authority [Member]
Research and development expense, CS participation percentage													50.00%
Israeli Innovation Authority [Member] | Maximum [Member]
Research and development expense					$ 924,166	₪ 3,594,082
Israeli Innovation Authority [Member] | ISRAEL
Research and development expense, CS participation percentage		60.00%	60.00%
Israeli Innovation Authority [Member] | ISRAEL | Maximum [Member]
Research and development expense		$ 794,963	₪ 3,041,529
Israeli Innovation Authority [Member] | Outside of Israel [Member]
Research and development expense, CS participation percentage		30.00%	30.00%
Israeli Innovation Authority [Member] | Outside of Israel [Member] | Maximum [Member]
Research and development expense		$ 215,630	₪ 825,000

X

- Definition

Participation Percentage

+ References

No definition available.

+ Details

Name:	mbot_ParticipationPercentage
Namespace Prefix:	mbot_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromConvertibleDebt
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mbot_IsraeliInnovationAuthorityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementGeographicalAxis=country_IL
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementGeographicalAxis=mbot_OtherCountriesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: